CKPTCheckpoint Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Mkt Cap$370.71M
Vol8.67M

About

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
24

Frequently Asked Questions

What is Market Cap of Checkpoint Therapeutics Inc?
What is the 52-week high for Checkpoint Therapeutics Inc?
What is the 52-week low for Checkpoint Therapeutics Inc?
What is Checkpoint Therapeutics Inc stock price today?
What was Checkpoint Therapeutics Inc stock price yesterday?
What is the PE ratio of Checkpoint Therapeutics Inc?
What is the Price-to-Book ratio of Checkpoint Therapeutics Inc?
What is the 50-day moving average of Checkpoint Therapeutics Inc?
How many employees does Checkpoint Therapeutics Inc have?

Advertisement|Remove ads.